Approval · Notice of Compliance 9782 · 2008
MYCAMINE: Notice of Compliance 9782
Issued September 12, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9782
- Date
- September 12, 2008
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication for the treatment of candidemia and invasive candidiasis
- Therapeutic class
- Antifungal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYCAMINE | Not yet assigned | — |
Medicinal ingredients
- MICAFUNGIN SODIUM 25 MG per VIAL
- MICAFUNGIN SODIUM 50 MG per VIAL
- MICAFUNGIN SODIUM 100 MG per VIAL